Recombinant multi-species CD163L1/CD163b protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CD163L1/CD163b protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the scavenger receptor cysteine-rich (SRCR) superfamily. Members of this family are secreted or membrane-anchored proteins mainly found in cells associated with the immune system. The SRCR family is defined by a 100-110 amino acid SRCR domain, which may mediate protein-protein interaction and ligand binding. The encoded protein contains twelve SRCR domains, a transmembrane region and a cytoplasmic domain. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
The Alternative Names of target: CD163 antigen-like 1,CD163B,CD163L1,CD163b,M160,SCARI2,STAR,Scavenger receptor cysteine-rich type 1 protein M160,WC1

Target products collectionGo to CD163L1/CD163b products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0073-Ag-1/ GM-Tg-hg-SE0073-Ag-2 Human CD163L1/CD163b protein Human
GM-Tg-rg-SE0073-Ag-1/ GM-Tg-rg-SE0073-Ag-2 Rat CD163L1/CD163b protein Rat
GM-Tg-mg-SE0073-Ag-1/ GM-Tg-mg-SE0073-Ag-2 Mouse CD163L1/CD163b protein Mouse
GM-Tg-cynog-SE0073-Ag-1/ GM-Tg-cynog-SE0073-Ag-2 Cynomolgus/Rhesus macaque CD163L1/CD163b protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0073-Ag-1/ GM-Tg-felg-SE0073-Ag-2 Feline CD163L1/CD163b protein Feline
GM-Tg-cang-SE0073-Ag-1/ GM-Tg-cang-SE0073-Ag-2 Canine CD163L1/CD163b protein Canine
GM-Tg-bovg-SE0073-Ag-1/ GM-Tg-bovg-SE0073-Ag-2 Bovine CD163L1/CD163b protein Bovine
GM-Tg-equg-SE0073-Ag-1/ GM-Tg-equg-SE0073-Ag-2 Equine CD163L1/CD163b protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0073-Ag-1/ GM-Tg-hg-SE0073-Ag-2; GM-Tg-rg-SE0073-Ag-1/ GM-Tg-rg-SE0073-Ag-2;
GM-Tg-mg-SE0073-Ag-1/ GM-Tg-mg-SE0073-Ag-2; GM-Tg-cynog-SE0073-Ag-1/ GM-Tg-cynog-SE0073-Ag-2;
GM-Tg-felg-SE0073-Ag-1/ GM-Tg-felg-SE0073-Ag-2; GM-Tg-cang-SE0073-Ag-1/ GM-Tg-cang-SE0073-Ag-2;
GM-Tg-bovg-SE0073-Ag-1/ GM-Tg-bovg-SE0073-Ag-2; GM-Tg-equg-SE0073-Ag-1/ GM-Tg-equg-SE0073-Ag-2
Products Name CD163L1/CD163b protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CD163L1/CD163b
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CD163L1/CD163b protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.